Research ArticleSafety and efficacy of viramidine versus ribavirin in ViSER2: Randomized, double-blind study in therapy-naive hepatitis C patients
Keywords: Hepatitis C; Viramidine; Weight-based dosing; Antiviral therapy; Anemia; Sustained virologic response; HCV; hepatitis C virus; peg-IFN; pegylated interferon; RBV; ribavirin; SVR; sustained virologic response; VRD; viramidine; ViSER2; Viramidine's Safety